143 related articles for article (PubMed ID: 7454937)
1. Sensitization and oscillation following repeated stimulation: relationship to affective illness and its treatment with lithium and carbamazepine [proceedings].
Post RM
Psychopharmacol Bull; 1980 Oct; 16(4):50-2. PubMed ID: 7454937
[No Abstract] [Full Text] [Related]
2. Electrooculography and dark adaptation in patients with affective and schizoaffective psychoses: early physiological effects of carbamazepine and lithium.
Kaschka WP; Thürauf N; Mokrusch T; Korth M
Pharmacopsychiatry; 1988 Nov; 21(6):404-6. PubMed ID: 3244776
[No Abstract] [Full Text] [Related]
3. [The use of carbamazepine in affective disorders].
Beresewicz M
Psychiatr Pol; 1994; 28(4):455-66. PubMed ID: 7972553
[TBL] [Abstract][Full Text] [Related]
4. Predictors of compliance with lithium and carbamazepine regimens in the long-term treatment of recurrent mood and related psychotic disorders.
Lenzi A; Lazzerini F; Placidi GF; Cassano GB; Akiskal HS
Pharmacopsychiatry; 1989 Jan; 22(1):34-7. PubMed ID: 2652160
[TBL] [Abstract][Full Text] [Related]
5. Sensitization, kindling, and carbamazepine: an update on their implications for the course of affective illness.
Post RM; Susan R; Weiss B
Pharmacopsychiatry; 1992 Jan; 25(1):41-3. PubMed ID: 1579606
[No Abstract] [Full Text] [Related]
6. [Prophylactic treatment of mood disorders: cost effectiveness analysis comparing lithium and carbamazepine].
Dardennes R; Lafuma A; Watkins S
Encephale; 1999; 25(5):391-400. PubMed ID: 10598301
[TBL] [Abstract][Full Text] [Related]
7. Neuroendocrine factors in affective disorders.
Tirrell C; DeForest D
Arch Psychiatr Nurs; 1987 Aug; 1(4):225-9. PubMed ID: 3650055
[No Abstract] [Full Text] [Related]
8. [Investigation on the therapeutic effect of carbamazepine on the mood disorders in Japan].
Okuma T
Seishin Shinkeigaku Zasshi; 2005; 107(5):415-22. PubMed ID: 15981617
[TBL] [Abstract][Full Text] [Related]
9. Choosing lithium, anticonvulsant, or electroconvulsant therapy for mood disorders.
Gross R; Grunhaus L
South Med J; 1995 Feb; 88(2):249-50. PubMed ID: 7839179
[No Abstract] [Full Text] [Related]
10. Carbamazepine and lithium carbonate in the treatment of refractory affective disorders.
Keisling R
Arch Gen Psychiatry; 1983 Feb; 40(2):223. PubMed ID: 6401989
[No Abstract] [Full Text] [Related]
11. [Prophylactic long-term therapy of affective disorders with lithium, valproic acid and carbamazepine--effectiveness and cost-effectiveness].
Roick C; Ahrens B; Becker T
Psychiatr Prax; 2001 Jul; 28 Suppl 1():S32-40. PubMed ID: 11533905
[TBL] [Abstract][Full Text] [Related]
12. Introduction: the use of mood stabilizers in the treatment of psychiatric disorders.
Bowden CL
J Clin Psychiatry; 1999; 60 Suppl 5():3-4. PubMed ID: 10192401
[No Abstract] [Full Text] [Related]
13. Biochemical mechanisms of action of carbamazepine in affective illness and epilepsy.
Post RM; Rubinow DR; Uhde TW
Psychopharmacol Bull; 1984; 20(3):585-9. PubMed ID: 6473665
[No Abstract] [Full Text] [Related]
14. Mechanisms of the psychotropic action of lithium and carbamazepine.
Rybakowski J
Pharmacol Toxicol; 1992; 71 Suppl 1():30-41. PubMed ID: 1480559
[No Abstract] [Full Text] [Related]
15. Practical therapeutics: the use of carbamazepine in affective disorders.
Obel AO; Odwako DB
East Afr Med J; 1985 Mar; 62(3):224-8. PubMed ID: 4017925
[No Abstract] [Full Text] [Related]
16. Carbamazepine in recurrent affective disorders?
Drug Ther Bull; 1986 Jul; 24(15):59-60. PubMed ID: 3525079
[No Abstract] [Full Text] [Related]
17. Carbamazepine and hyponatremia.
Vieweg WV; Godleski LS
Am J Psychiatry; 1988 Oct; 145(10):1323-4. PubMed ID: 3421371
[No Abstract] [Full Text] [Related]
18. Modulation of CNS signal transduction pathways and gene expression by mood-stabilizing agents: therapeutic implications.
Manji HK; Bebchuk JM; Moore GJ; Glitz D; Hasanat KA; Chen G
J Clin Psychiatry; 1999; 60 Suppl 2():27-39; discussion 40-1, 113-6. PubMed ID: 10073385
[TBL] [Abstract][Full Text] [Related]
19. 5-Hydroxytryptamine in the pathogenesis of affective disorders.
Coppen A; Wood K
Adv Biochem Psychopharmacol; 1982; 34():249-58. PubMed ID: 6753513
[No Abstract] [Full Text] [Related]
20. Carbamazepine for patients with affective target symptoms.
Jann MW; Saklad SR; Ereshefsky L
Drug Intell Clin Pharm; 1984 Jan; 18(1):81. PubMed ID: 6692752
[No Abstract] [Full Text] [Related]
[Next] [New Search]
